Cargando…
Targeting STAT3 in Cancer with Nucleotide Therapeutics
Signal transducer and activator of transcription 3 (STAT3) plays a critical role in promoting the proliferation and survival of tumor cells. As a ubiquitously-expressed transcription factor, STAT3 has commonly been considered an “undruggable” target for therapy; thus, much research has focused on ta...
Autores principales: | K. Lau, Yue-Ting, Ramaiyer, Malini, E. Johnson, Daniel, R. Grandis, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896109/ https://www.ncbi.nlm.nih.gov/pubmed/31671769 http://dx.doi.org/10.3390/cancers11111681 |
Ejemplares similares
-
Critical analysis of the potential for targeting STAT3 in human malignancy
por: Peyser, Noah D, et al.
Publicado: (2013) -
Targeting the JAK/STAT pathway in solid tumors
por: Qureshy, Zoya, et al.
Publicado: (2020) -
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
por: Peyser, Noah D., et al.
Publicado: (2015) -
STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors
por: Ramasamy, Thiruganesh, et al.
Publicado: (2020) -
Nucleic acid-based approaches to STAT inhibition
por: Sen, Malabika, et al.
Publicado: (2012)